The event will host leading scientists from academia, industry, and the vendor community to discuss recent advancements in the discovery of therapeutic OLIGOs and in the chemical biology research field in Europe and internationally. The event aims to create an open access meeting and an inspiring environment for networking between biologists and chemists to fuel cross-fertilization between research areas.
Topics
- Therapeutic OLIGO profiling
- Advancements in OLIGO design and synthesis
- Novel formulations and biomarker analysis
- New ways to shape and interrogate biology through chemistry
- Chemical probe-induced protein interaction and degradation
- Innovative tools and methods for advanced cell profiling
Selected Speakers
- Anna Backmark, AstraZeneca R&D Gothenburg, Sweden
- Petr Bartunek, CZ-OPENSCREEN, Czech Republic
- Frank Bennett, Ionis Pharmaceuticals, USA
- Tom Brown, Oxfork University, UK
- Mads Clausen, DTU Chemistry, Denmark
- Peter Crowley, University of Galway, Ireland
- Katherine Donovan, Dana-Farber Cancer Insitute, USA
- Steven Dowdy, UCSD School of Medicine, USA
- Samir EL Andaloussi, Karolinska Institutet, Sweden
- Simon Elsässer, Karolinska Insitutet, Sweden
- Alice Ghidini, Sixfold, UK
- Heather Gildie, Helleday Laboratory, Sweden
- Aurelie Goyenvalle, Inserm – University of Versailles, France
- Anna-Lena Gustavsson, Karolinska Institutet SciLifeLab, Sweden
- Peter Hagedorn, Roche, Denmark
- Juanitta Vibeke Julsgart, Fida Biosystems ApS, Denmark
- Emma Kay, AstraZeneca, Sweden
- Stefan Kubicek, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria
- Michael Kurczy, AstraZeneca, Sweden
- Kai Liu, AstraZeneca, Sweden
